# A Phase 1 Study of the Safety and Pharmacokinetics of GC4711 (Oral Capsule) Compared to GC4419 (IV Infusion) and GC4711 (IV Infusion) in Healthy Volunteers

> **NCT03099824** · PHASE1 · COMPLETED · sponsor: **Galera Therapeutics, Inc.** · enrollment: 56 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** GC4711 Oral Capsule G-101
- **DRUG:** IV GC4419
- **DRUG:** GC4711 Oral Capsule G-101
- **DRUG:** GC4711 Oral Capsule G-101
- **DRUG:** GC4711 Oral Capsule G-111
- **DRUG:** GC4711 Oral Capsule G-112
- **DRUG:** GC4711 Oral Capsule G-119
- **DRUG:** GC4711 Oral Capsule G-125
- **DRUG:** IV GC4711

## Key facts

- **NCT ID:** NCT03099824
- **Lead sponsor:** Galera Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-16
- **Primary completion:** 2020-01-27
- **Final completion:** 2020-01-27
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2021-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03099824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03099824, "A Phase 1 Study of the Safety and Pharmacokinetics of GC4711 (Oral Capsule) Compared to GC4419 (IV Infusion) and GC4711 (IV Infusion) in Healthy Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03099824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*